Royal Bank of Canada’s Rein Therapeutics, Inc. Common Stock RNTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-57,257
| Closed | -$101K | – | 6971 |
|
2025
Q1 | $101K | Sell |
57,257
-49,715
| -46% | -$87.7K | ﹤0.01% | 4862 |
|
2024
Q4 | $246K | Buy |
106,972
+98,972
| +1,237% | +$228K | ﹤0.01% | 4200 |
|
2024
Q3 | $28K | Sell |
8,000
-52,241
| -87% | -$183K | ﹤0.01% | 5521 |
|
2024
Q2 | $167K | Buy |
60,241
+24,241
| +67% | +$67.2K | ﹤0.01% | 4522 |
|
2024
Q1 | $239K | Buy |
+36,000
| New | +$239K | ﹤0.01% | 4119 |
|
2023
Q2 | – | Sell |
-25
| Closed | – | – | 7176 |
|
2023
Q1 | $0 | Buy |
25
+23
| +1,150% | – | ﹤0.01% | 7010 |
|
2022
Q4 | $0 | Buy |
+2
| New | – | ﹤0.01% | 7240 |
|
2020
Q3 | – | Sell |
-31
| Closed | -$1K | – | 6405 |
|
2020
Q2 | $1K | Hold |
31
| – | – | ﹤0.01% | 6020 |
|
2020
Q1 | $0 | Buy |
+31
| New | – | ﹤0.01% | 6370 |
|
2019
Q4 | – | Sell |
-32
| Closed | – | – | 6390 |
|
2019
Q3 | $0 | Buy |
32
+31
| +3,100% | – | ﹤0.01% | 6222 |
|
2019
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 6064 |
|
2019
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 5976 |
|
2018
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 6175 |
|
2018
Q3 | $0 | Buy |
+1
| New | – | ﹤0.01% | 6293 |
|
2018
Q2 | – | Hold |
0
| – | – | – | 6108 |
|
2018
Q1 | – | Hold |
0
| – | – | – | 6028 |
|
2017
Q4 | – | Sell |
-22
| Closed | -$6K | – | 6083 |
|
2017
Q3 | $6K | Buy |
+22
| New | +$6K | ﹤0.01% | 5641 |
|